Skip to content
2000
image of KLHL17 as a Prognostic Indicator and Therapeutic Target in Cervical Cancer: A Comprehensive Analysis

Abstract

Introduction

This study aims to clarify the role of kelch like family member 17 (KLHL17) in cervical cancer (CESC) is unclear.

Objective

To clarify this uncertainty, our research employed bioinformatics analysis coupled with experimental corroboration.

Methods

We utilized the Cancer Genome Atlas (TCGA) database to assess the expression of KLHL17 in various cancers, specifically CESC, and to explore its association with clinical characteristics, diagnostic utility, and prognostic significance in CESC. The current investigation delved into the potential regulatory pathways related to KLHL17, examining its connection with the infiltration of immune cells, the expression of immune checkpoint genes, the status of microsatellite instability (MSI), and the efficacy of diverse therapeutic agents in CESC. The research analyzed KLHL17 expression patterns using single-cell sequencing data from CESC samples and investigated the genetic variations of KLHL17 within this context. KLHL17 expression was validated using GSE145372. The presence and levels of KLHL17 in different cell lines were validated through quantitative real-time PCR (qRT-PCR) assays.

Results

KLHL17 exhibited irregular expression profiles across various cancer types, including CESC. Furthermore, increased KLHL17 levels in CESC patients were significantly associated with a lower progression-free survival (PFS) rate (hazard ratio: 1.62; 95% confidence interval: 1.01–2.60, p = 0.044). Moreover, KLHL17 expression emerged as a distinct prognostic indicator for CESC patients (p = 0.031). It has been associated with various biological pathways, such as cytokine-cytokine receptor interaction, primary immunodeficiency, cell adhesion molecules (CAMs), chemokine signaling pathway, steroid hormone biosynthesis, and others. The expression levels of KLHL17 were found to correlate with the presence of immune cells, the expression of immune checkpoint genes, and the status of MSI within CESC. Furthermore, KLHL17 expression exhibited a significant and inverse correlation with XMD15-27, rTRAIL, Paclitaxel, tp4ek, and tp4ek-k6. Furthermore, KLHL17 was found to be significantly positively regulated in CESC cell lines.

Discussion

The findings suggest that KLHL17 is involved in the progression of CESC and may serve as a potential prognostic marker and therapeutic target. KLHL17's association with immune cell infiltration and immune checkpoint genes indicates a role in immuneevasion. Future research should focus on validating these findings through independent datasets and experimental studies to elucidate the molecular mechanisms underlying KLHL17's role in CESC progression and immune regulation.

Conclusion

KLHL17 is a promising prognostic marker and potential therapeutic target in CESC.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073378446250417123724
2025-05-13
2025-09-14

  • From This Site

    /content/journals/cchts/10.2174/0113862073378446250417123724
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Siegel R.L. Miller K.D. Fuchs H.E. Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 2022 72 1 7 33 10.3322/caac.21708 35020204
    [Google Scholar]
  2. Duan R. Qiao Y. Clifford G. Zhao F. Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. Cancer Med. 2020 9 1 374 384 10.1002/cam4.2697 31714036
    [Google Scholar]
  3. Markowitz L.E. Liu G. Hariri S. Steinau M. Dunne E.F. Unger E.R. Prevalence of HPV after introduction of the vaccination program in the united states. Pediatrics 2016 137 3 e20151968 10.1542/peds.2015‑1968 26908697
    [Google Scholar]
  4. Torres-Roman J.S. Ronceros-Cardenas L. Valcarcel B. Bazalar-Palacios J. Ybaseta-Medina J. Carioli G. La Vecchia C. Alvarez C.S. Cervical cancer mortality among young women in latin america and the caribbean: Trend analysis from 1997 to 2030. BMC Public Health 2022 22 1 113 10.1186/s12889‑021‑12413‑0 35034604
    [Google Scholar]
  5. Yang J. Mead-Harvey C. Polen-De C. Magtibay P. Butler K. Cliby W. Langstraat C. Dinh T. Chen L. Magrina J. Survival outcomes in patients with cervical cancer treated with open versus robotic radical hysterectomy: Our surgical pathology interrogation. Gynecol. Oncol. 2020 159 2 373 380 10.1016/j.ygyno.2020.08.031 32893029
    [Google Scholar]
  6. Yang H. Ye S. Goswami S. Li T. Wu J. Cao C. Ma J. Lu B. Pei X. Chen Y. Yu J. Xu H. Qiu L. Afridi S. Xiang L. Zhang X. Highly immunosuppressive HLADR hi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma. Int. J. Cancer 2020 146 7 1993 2006 10.1002/ijc.32782 31709528
    [Google Scholar]
  7. Mulita F. Verras G.I. Anagnostopoulos C.N. Kotis K. A smarter health through the internet of surgical things. Sensors (Basel) 2022 22 12 4577 10.3390/s22124577 35746359
    [Google Scholar]
  8. Dhanoa B.S. Cogliati T. Satish A.G. Bruford E.A. Friedman J.S. Update on the Kelch-like (KLHL) gene family. Hum. Genomics 2013 7 1 13 10.1186/1479‑7364‑7‑13 23676014
    [Google Scholar]
  9. Jeong Y. Oh A.R. Jung Y.H. Gi H. Kim Y.U. Kim K. Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases. Exp. Mol. Med. 2023 55 10 2097 2104 10.1038/s12276‑023‑01087‑w 37779139
    [Google Scholar]
  10. Paciorkowski A.R. Thio L.L. Rosenfeld J.A. Gajecka M. Gurnett C.A. Kulkarni S. Chung W.K. Marsh E.D. Gentile M. Reggin J.D. Wheless J.W. Balasubramanian S. Kumar R. Christian S.L. Marini C. Guerrini R. Maltsev N. Shaffer L.G. Dobyns W.B. Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur. J. Hum. Genet. 2011 19 12 1238 1245 10.1038/ejhg.2011.121 21694734
    [Google Scholar]
  11. Hu H.T. Hsueh Y.P. KLHL17 differentially controls the expression of AMPA- and KA-type glutamate receptors to regulate dendritic spine enlargement. J. Neurochem. 2024 168 9 2155 2169 10.1111/jnc.16148 38898681
    [Google Scholar]
  12. Hu H.T. Lin Y.J. Wang U.T.T. Lee S.P. Liou Y.H. Chen B.C. Hsueh Y.P. Autism-related KLHL17 and SYNPO act in concert to control activity-dependent dendritic spine enlargement and the spine apparatus. PLoS Biol. 2023 21 8 e3002274 10.1371/journal.pbio.3002274 37651441
    [Google Scholar]
  13. Zhou Q. Guo D. Shen T. Jiang H. Identification of KLHL17 as a prognostic marker for prostate cancer based on single-cell sequencing and in vitro/in vivo experiments. Discover Oncology 2024 15 1 524 10.1007/s12672‑024‑01406‑1 39365488
    [Google Scholar]
  14. Liu Z. Zhao M. Jiang X. Zhang Y. Zhang S. Xu Y. Ren H. Su H. Wang H. Qiu X. Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway. Lab. Invest. 2022 102 12 1389 1399 10.1038/s41374‑022‑00806‑7 35978057
    [Google Scholar]
  15. Chen B. Lu X. Zhou Q. Chen Q. Zhu S. Li G. Liu H. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer. PLoS One 2023 18 8 e0290031 10.1371/journal.pone.0290031 37582104
    [Google Scholar]
  16. Huang Z. Hu X. Wei Y. Lai Y. Qi J. Pang J. Huang K. Li H. Cai P. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. PLoS One 2024 19 5 e0303909 10.1371/journal.pone.0303909 38814950
    [Google Scholar]
  17. Yang D. Liu M. Jiang J. Luo Y. Wang Y. Chen H. Li D. Wang D. Yang Z. Chen H. Comprehensive analysis of DMRT3 as a potential biomarker associated with the immune infiltration in a pan-cancer analysis and validation in lung adenocarcinoma. Cancers (Basel) 2022 14 24 6220 10.3390/cancers14246220 36551704
    [Google Scholar]
  18. Zhao X. Lu M. Liu Z. Zhang M. Yuan H. Dan Z. Wang D. Ma B. Yang Y. Yang F. Sun R. Li L. Dang C. Comprehensive analysis of alfa defensin expression and prognosis in human colorectal cancer. Front. Oncol. 2023 12 974654 10.3389/fonc.2022.974654 36703795
    [Google Scholar]
  19. Guo X. Zhang Y. Peng L. Wang Y. He C.W. Li K. Hao K. Li K. Wang Z. Huang H. Miao X. Collagen synthase P4HA3 as a novel biomarker for colorectal cancer correlates with prognosis and immune infiltration. Heliyon 2024 10 11 e31695 10.1016/j.heliyon.2024.e31695 38832271
    [Google Scholar]
  20. Ding H. Zhang L. Zhang C. Song J. Jiang Y. Screening of significant biomarkers related to prognosis of cervical cancer and functional study based on lncRNA-associated ceRNA regulatory network. Comb. Chem. High Throughput Screen. 2021 24 3 472 482 10.2174/1386207323999200729113028 32729415
    [Google Scholar]
  21. Du Q. Xing N. Guo S. Meng X. Zhang Y. Wang S. Cycas revoluta leaves: As a potential flavonoids source for targeted regulation of immune-related markers in lung adenocarcinoma. Ind. Crops Prod. 2023 202 116967 10.1016/j.indcrop.2023.116967
    [Google Scholar]
  22. Xu L. Li W. Yang T. Hu S. Zou Q. Jiao J. Jiang N. Zhang Y. Immune-related RNA-binding protein-based signature with predictive and prognostic implications in patients with lung adenocarcinoma. Front. Mol. Biosci. 2022 9 807622 10.3389/fmolb.2022.807622 35647031
    [Google Scholar]
  23. Tao S. Cui D. Cheng H. Liu X. Jiang Z. Chen H. Gao Y. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma. BMC Cancer 2024 24 1 194 10.1186/s12885‑024‑11943‑1 38347489
    [Google Scholar]
  24. Yi W. Shen H. Sun D. Xu Y. Feng Y. Li D. Wang C. Low expression of long noncoding RNA SLC26A4 antisense RNA 1 is an independent prognostic biomarker and correlate of immune infiltrates in breast cancer. Med. Sci. Monit. 2022 28 e934522 10.12659/MSM.934522 34880202
    [Google Scholar]
  25. Shen Y. Shi Y. Liu X. Zhang M. Zhou L. Xu C. KLF15 transcription activated tachykinin precursor 1 to induce perineural invasion in head and neck squamous cell carcinoma. Comb. Chem. High Throughput Screen. 2024 28 1 9 10.2174/0113862073331908241002044719 39411944
    [Google Scholar]
  26. Chen J. Tang H. Li T. Jiang K. Zhong H. Wu Y. He J. Li D. Li M. Cai X. Comprehensive analysis of the expression, prognosis, and biological significance of OVOLs in breast cancer. Int. J. Gen. Med. 2021 14 3951 3960 10.2147/IJGM.S326402 34345183
    [Google Scholar]
  27. Cai H. Chen S. Wu Z. Wang F. Tang S. Li D. Wang D. Guo W. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma. Aging (Albany NY) 2023 15 22 13041 13058 10.18632/aging.205218 37980166
    [Google Scholar]
  28. Chen Y. Xu H. Tang H. Li H. Zhang C. Jin S. Bai D. miR-9-5p expression is associated with vascular invasion and prognosis in hepatocellular carcinoma, and in vitro verification. J. Cancer Res. Clin. Oncol. 2023 149 16 14657 14671 10.1007/s00432‑023‑05257‑1 37584711
    [Google Scholar]
  29. Liang D. Zhang Q. Pang Y. Yan R. Ke Y. SGSM2 in uveal melanoma: implications for survival, immune infiltration, and drug sensitivity. Protein Pept. Lett. 2024 31 11 894 905 10.2174/0109298665341953240926041613 39501960
    [Google Scholar]
  30. Liang W. Lu Y. Pan X. Zeng Y. Zheng W. Li Y. Nie Y. Li D. Wang D. Decreased expression of a novel lncRNA FAM181A-AS1 is associated with poor prognosis and immune infiltration in lung adenocarcinoma. Pharm. Genomics Pers. Med. 2022 15 985 998 10.2147/PGPM.S384901 36482943
    [Google Scholar]
  31. Liang L. Xu H. Dong Q. Qiu L. Lu L. Yang Q. Zhao W. Li Y. WTAP is correlated with unfavorable prognosis, tumor cell proliferation, and immune infiltration in hepatocellular carcinoma. Front. Oncol. 2022 12 852000 10.3389/fonc.2022.852000 35480109
    [Google Scholar]
  32. Lin Z. Huang W. Yi Y. Li D. Xie Z. Li Z. Ye M. LncRNA ADAMTS9-AS2 is a prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma. Int. J. Gen. Med. 2021 14 8541 8555 10.2147/IJGM.S340683 34849000
    [Google Scholar]
  33. Lu X. Jing L. Liu S. Wang H. Chen B. miR-149-3p is a potential prognosis biomarker and correlated with immune infiltrates in uterine corpus endometrial carcinoma. Int. J. Endocrinol. 2022 2022 1 15 10.1155/2022/5006123 35719192
    [Google Scholar]
  34. Xing S. Li D. Zhao Q. RPL22L1 is a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma, promoting the growth and metastasis of LUAD cells by inhibiting the MDM2/P53 signaling pathway. Aging (Albany NY) 2024 16 17 12392 12413 10.18632/aging.206096 39207452
    [Google Scholar]
  35. Bindea G. Mlecnik B. Tosolini M. Kirilovsky A. Waldner M. Obenauf A.C. Angell H. Fredriksen T. Lafontaine L. Berger A. Bruneval P. Fridman W.H. Becker C. Pagès F. Speicher M.R. Trajanoski Z. Galon J. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013 39 4 782 795 10.1016/j.immuni.2013.10.003 24138885
    [Google Scholar]
  36. Hänzelmann S. Castelo R. Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 2013 14 1 7 10.1186/1471‑2105‑14‑7 23323831
    [Google Scholar]
  37. Lu Z.M. Pan S.L. Yuan W.L. Feng J.L. Tian D. Shang X.Q. Molecular and immunological characteristics of patients with CMTM6 low expression colorectal cancer. Medicine (Baltimore) 2023 102 50 e36480 10.1097/MD.0000000000036480 38115316
    [Google Scholar]
  38. Yoshihara K. Shahmoradgoli M. Martínez E. Vegesna R. Kim H. Torres-Garcia W. Treviño V. Shen H. Laird P.W. Levine D.A. Carter S.L. Getz G. Stemke-Hale K. Mills G.B. Verhaak R.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013 4 1 2612 10.1038/ncomms3612 24113773
    [Google Scholar]
  39. Rong Y. Liu S.H. Tang M.Z. Wu Z.H. Ma G.R. Li X.F. Cai H. Analysis of the potential biological value of pyruvate dehydrogenase E1 subunit β in human cancer. World J. Gastrointest. Oncol. 2024 16 1 144 181 10.4251/wjgo.v16.i1.144 38292838
    [Google Scholar]
  40. Yuan Z. Wang L. Chen C. Analysis of the prognostic, diagnostic and immunological role of HSP90α in malignant tumors. Front. Oncol. 2022 12 963719 10.3389/fonc.2022.963719 36158677
    [Google Scholar]
  41. Cen S. Yang G. Bao H. Yu Z. Liang L. Impact of propofol versus sevoflurane anesthesia on molecular subtypes and immune checkpoints of glioma during surgery. Health Sci. Rep. 2023 6 9 e1366 10.1002/hsr2.1366 37706017
    [Google Scholar]
  42. Xu Z. Pei C. Cheng H. Song K. Yang J. Li Y. He Y. Liang W. Liu B. Tan W. Li X. Pan X. Meng L. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma. Front. Immunol. 2023 14 1138524 10.3389/fimmu.2023.1138524 37234166
    [Google Scholar]
  43. Chen B. Ding X. Wan A. Qi X. Lin X. Wang H. Mu W. Wang G. Zheng J. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer. Sci. Rep. 2023 13 1 16244 10.1038/s41598‑023‑42171‑5 37758722
    [Google Scholar]
  44. Ding X. Wan A. Qi X. Jiang K. Liu Z. Chen B. ZNF695, a potential prognostic biomarker, correlates with immune infiltrates in cervical squamous cell carcinoma and endoce rvical adenocarcinoma: bioinformatic analysis and experimental verification. Curr. Gene Ther. 2024 24 5 441 452 10.2174/0115665232285216240228071244 38441026
    [Google Scholar]
  45. Liu W.Z. Yu M.M. Kang M. Study on the mechanism of Astragalus polysaccharides on cervical cancer based on network pharmacology. Comb. Chem. High Throughput Screen. 2023 26 8 1547 1559 10.2174/1386207326666230118121436 36654467
    [Google Scholar]
  46. Becker L.S. Al Smadi M.A. Koch H. Abdul-Khaliq H. Meese E. Abu-Halima M. Towards a more comprehensive picture of the MicroRNA-23a/b-3p impact on impaired male fertility. Biology (Basel) 2023 12 6 800 10.3390/biology12060800 37372085
    [Google Scholar]
  47. Han Q. Cui Z. Wang Q. Pang F. Li D. Wang D. Upregulation of OTX2-AS1 is associated with immune infiltration and predicts prognosis of gastric cancer. Technol. Cancer Res. Treat. 2023 22 15330338231154091 10.1177/15330338231154091 36740995
    [Google Scholar]
  48. Huang Y.S. Fang T.H. Kung B. Chen C.H. Two genetic mechanisms in two siblings with intellectual disability, autism spectrum disorder, and psychosis. J. Pers. Med. 2022 12 6 1013 10.3390/jpm12061013 35743796
    [Google Scholar]
  49. Shi B. Chu J. Huang T. Wang X. Li Q. Gao Q. Xia Q. Luo S. The scavenger receptor MARCO expressed by tumor-associated macrophages are highly associated with poor pancreatic cancer prognosis. Front. Oncol. 2021 11 771488 10.3389/fonc.2021.771488 34778091
    [Google Scholar]
  50. Gao X. Le Y. Geng C. Jiang Z. Zhao G. Zhang P. DPP4 is a potential prognostic marker of thyroid carcinoma and a target for immunotherapy. Int. J. Endocrinol. 2022 2022 1 11 10.1155/2022/5181386 36467461
    [Google Scholar]
  51. Handzlik G. Szymańska E. Pękala E. Kędzierski L. Strzałkowska D. Duława J. Low sodium dietary approach in the management of resistant and refractory hypertension: Preliminary results. Pol. Arch. Intern. Med. 2021 131 10 16098 10.20452/pamw.16098 34581172
    [Google Scholar]
  52. Zhang Y. Zhou Y. Wei F. circABCB10 promotes malignant progression of gastric cancer cells by preventing the degradation of MYC. J. Oncol. 2021 2021 1 14 10.1155/2021/4625033 34950208
    [Google Scholar]
  53. Ma X. Zheng J. He K. Wang L. Wang Z. Wang K. Liu Z. San Z. Zhao L. Wang L. TGFA expression is associated with poor prognosis and promotes the development of cervical cancer. J. Cell. Mol. Med. 2024 28 3 e18086 10.1111/jcmm.18086 38152044
    [Google Scholar]
  54. Zhao Y.C. Wang T.J. Cui J. She L.Z. Zhang R.F. Zhang C.H. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer. Transl. Oncol. 2024 40 101839 10.1016/j.tranon.2023.101839 38029507
    [Google Scholar]
  55. Li G. Chen Q. Hong S. Yang X. Liang X. Yang J. CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor. J. Cancer 2024 15 2 444 455 10.7150/jca.87622 38169557
    [Google Scholar]
  56. Zhang S.Q. Zhang J. Yu Y. Yu M.M. Wei J. Tang Y.H. APOBEC3B expression has prognostic significance in cervical cancer. Int. J. Clin. Exp. Pathol. 2023 16 3 48 56 37033395
    [Google Scholar]
  57. Zhao Y.C. Wang T.J. Qu G.H. She L.Z. Cui J. Zhang R.F. Qu H.D. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior in vivo and in vitro. Am. J. Cancer Res. 2023 13 7 3123 3139 37559998
    [Google Scholar]
  58. Zheng X. Xu H. Yi X. Zhang T. Wei Q. Li H. Ai J. Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine. Mol. Cancer 2021 20 1 160 10.1186/s12943‑021‑01452‑1 34872584
    [Google Scholar]
  59. Ding B. Sun W. Han S. Cai Y. Ren M. Shen Y. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk. Medicine (Baltimore) 2018 97 13 e0210 10.1097/MD.0000000000010210 29595663
    [Google Scholar]
  60. Al-saraireh Y.M. Alshammari F.O.F.O. Youssef A.M.M. Al-sarayra Y.M. Al-saraireh R.A. Al-muhaisen G.H. Al-mahdy Y.S. Al-Kharabsheh A.M. Abufraijeh S.M. Alrawashdeh H.M. Cytochrome 4Z1 expression is correlated with poor prognosis in patients with cervical cancer. Curr. Oncol. 2021 28 5 3573 3584 10.3390/curroncol28050306 34590601
    [Google Scholar]
  61. Zhang X. Dai B. Zhang B. Wang Z. Vitamin A and risk of cervical cancer: A meta-analysis. Gynecol. Oncol. 2012 124 2 366 373 10.1016/j.ygyno.2011.10.012 22005522
    [Google Scholar]
  62. Toro de Méndez M. Bosch A.L. Abnormal immunoexpression of cell adhesion molecules (CAMs) in cervical cancer. Int. J. Surg. Pathol. 2011 19 6 733 742 10.1177/1066896909343435 20643667
    [Google Scholar]
  63. Liu L.B. Xie F. Chang K.K. Shang W.Q. Meng Y.H. Yu J.J. Li H. Sun Q. Yuan M.M. Jin L.P. Li D.J. Li M.Q. Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell. Am. J. Cancer Res. 2015 5 10 3072 3084 26693060
    [Google Scholar]
  64. de Villiers E.M. Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int. J. Cancer 2003 103 6 705 708 10.1002/ijc.10868 12516087
    [Google Scholar]
  65. Jia Y. Yang N. Tang S. Deng L. Wang Y. Cai X. RUNX1 promotes proliferation of cervical cancer through TGFB2-MAPK pathway. Sci. Rep. 2025 15 1 497 10.1038/s41598‑024‑84254‑x 39747496
    [Google Scholar]
  66. Shiri Aghbash P. Rasizadeh R. Sadri Nahand J. Bannazadeh Baghi H. The role of immune cells and inflammasomes in Modulating cytokine responses in HPV-Related cervical cancer. Int. Immunopharmacol. 2025 145 113625 10.1016/j.intimp.2024.113625 39637578
    [Google Scholar]
  67. Bonneville R. Krook M.A. Kautto E.A. Miya J. Wing M.R. Chen H.Z. Reeser J.W. Yu L. Roychowdhury S. Landscape of microsatellite instability across 39 cancer types. JCO Precis. Oncol. 2017 2017 00073 10.1200/PO.17.00073 29850653
    [Google Scholar]
/content/journals/cchts/10.2174/0113862073378446250417123724
Loading
KLHL17 as a Prognostic Indicator and Therapeutic Target in Cervical Cancer: A Comprehensive Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0113862073378446250417123724
/content/journals/cchts/10.2174/0113862073378446250417123724
/content/journals/cchts/10.2174/0113862073378446250417123724
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: MSI ; drug susceptibility ; prognosis ; CESC ; KLHL17 ; immune response

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test